[22] Snake venom proteases that activate blood-coagulation factor V

This chapter presents the procedure for purification and assaying of Russell's viper venom (RVV). The procedures for the isolation of RVV-V and thrombocytin used in this laboratory are virtually identical and include an initial gel filtration of the crude venom followed by final purification of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Methods in Enzymology 1981, Vol.80, p.275-285
Hauptverfasser: Kisiel, Walter, Canfield, William M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 285
container_issue
container_start_page 275
container_title Methods in Enzymology
container_volume 80
creator Kisiel, Walter
Canfield, William M.
description This chapter presents the procedure for purification and assaying of Russell's viper venom (RVV). The procedures for the isolation of RVV-V and thrombocytin used in this laboratory are virtually identical and include an initial gel filtration of the crude venom followed by final purification of the enzyme by SPSephadex ion-exchange chromatography. Because both of these enzymes are highly cationic, plasticware is recommended in the collection and storage of these proteins. In the assay venom protease is incubated with factor V substrate for a defined period. Following the incubation period, factor V is assayed by its ability to correct the clotting time of human factor V-deficient plasma following addition of tissue factor and calcium ions. The clotting times in this assay are proportional to the concentration of factor Va present in the incubation mixture, which in turn is directly related to the concentration of the venom factor V activator. In the assay of RVV-V, barium sulfateadsorbed plasma is a satisfactory source of factor V. In the assay of thrombocytin, however, partially purified factor V is required in that B. atrox venom contains a thrombin-like protease (batroxabin) that coelutes with thrombocytin in gel-filtration columns.
doi_str_mv 10.1016/S0076-6879(81)80024-9
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73946716</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0076687981800249</els_id><sourcerecordid>73946716</sourcerecordid><originalsourceid>FETCH-LOGICAL-c314t-97b38b5e020cd7ab6e4e65fc993f6870273f7ce2ec35efef61a2e8ac69e634a63</originalsourceid><addsrcrecordid>eNo9kMlOwzAQhi0WlVL6CJVyQnAIeEm8nBCq2KRKHApcELIcZwKGJIbYqcTbky5iLnP4P43--RCaEXxBMOGXS4wFT7kU6kySc4kxzVK1h8Ykz0UqlJT76BgTSiRREqsDNP7nj9A0hE88TC4EE2SERgJnjCg6RvNXSt-SZWu-IFlB65vku_MRTICQxA8TE2OjW5kISVF7X6bWm_e-NtH5NqmGzHfJywk6rEwdYLrbE_R8e_M0v08Xj3cP8-tFahnJYqpEwWSRA6bYlsIUHDLgeWWVYtVQE1PBKmGBgmU5VFBxYihIY7kCzjLD2QSdbu8OFX96CFE3Llioa9OC74MWTGVckDU424F90UCpvzvXmO5X774e8qttDkPblYNOB-ugtVC6DmzUpXeaYL3Wrjfa9VqjlkRvtGvF_gCXhXEZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73946716</pqid></control><display><type>article</type><title>[22] Snake venom proteases that activate blood-coagulation factor V</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ScienceDirect eBooks</source><creator>Kisiel, Walter ; Canfield, William M.</creator><creatorcontrib>Kisiel, Walter ; Canfield, William M.</creatorcontrib><description>This chapter presents the procedure for purification and assaying of Russell's viper venom (RVV). The procedures for the isolation of RVV-V and thrombocytin used in this laboratory are virtually identical and include an initial gel filtration of the crude venom followed by final purification of the enzyme by SPSephadex ion-exchange chromatography. Because both of these enzymes are highly cationic, plasticware is recommended in the collection and storage of these proteins. In the assay venom protease is incubated with factor V substrate for a defined period. Following the incubation period, factor V is assayed by its ability to correct the clotting time of human factor V-deficient plasma following addition of tissue factor and calcium ions. The clotting times in this assay are proportional to the concentration of factor Va present in the incubation mixture, which in turn is directly related to the concentration of the venom factor V activator. In the assay of RVV-V, barium sulfateadsorbed plasma is a satisfactory source of factor V. In the assay of thrombocytin, however, partially purified factor V is required in that B. atrox venom contains a thrombin-like protease (batroxabin) that coelutes with thrombocytin in gel-filtration columns.</description><identifier>ISSN: 0076-6879</identifier><identifier>ISBN: 0121819809</identifier><identifier>ISBN: 9780121819804</identifier><identifier>EISSN: 1557-7988</identifier><identifier>DOI: 10.1016/S0076-6879(81)80024-9</identifier><identifier>PMID: 7043192</identifier><language>eng</language><publisher>United States: Elsevier Science &amp; Technology</publisher><subject>Animals ; Cattle ; Crotalid Venoms - isolation &amp; purification ; Crotalid Venoms - pharmacology ; Endopeptidases - isolation &amp; purification ; Endopeptidases - pharmacology ; Factor V - metabolism ; Factor Va ; Humans ; Peptide Hydrolases - isolation &amp; purification ; Peptide Hydrolases - pharmacology ; Serine Endopeptidases ; Snakes ; Viper Venoms - isolation &amp; purification ; Viper Venoms - pharmacology</subject><ispartof>Methods in Enzymology, 1981, Vol.80, p.275-285</ispartof><rights>1981</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c314t-97b38b5e020cd7ab6e4e65fc993f6870273f7ce2ec35efef61a2e8ac69e634a63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0076-6879(81)80024-9$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,779,780,784,793,3459,3550,4024,11288,27923,27924,27925,45810,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7043192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kisiel, Walter</creatorcontrib><creatorcontrib>Canfield, William M.</creatorcontrib><title>[22] Snake venom proteases that activate blood-coagulation factor V</title><title>Methods in Enzymology</title><addtitle>Methods Enzymol</addtitle><description>This chapter presents the procedure for purification and assaying of Russell's viper venom (RVV). The procedures for the isolation of RVV-V and thrombocytin used in this laboratory are virtually identical and include an initial gel filtration of the crude venom followed by final purification of the enzyme by SPSephadex ion-exchange chromatography. Because both of these enzymes are highly cationic, plasticware is recommended in the collection and storage of these proteins. In the assay venom protease is incubated with factor V substrate for a defined period. Following the incubation period, factor V is assayed by its ability to correct the clotting time of human factor V-deficient plasma following addition of tissue factor and calcium ions. The clotting times in this assay are proportional to the concentration of factor Va present in the incubation mixture, which in turn is directly related to the concentration of the venom factor V activator. In the assay of RVV-V, barium sulfateadsorbed plasma is a satisfactory source of factor V. In the assay of thrombocytin, however, partially purified factor V is required in that B. atrox venom contains a thrombin-like protease (batroxabin) that coelutes with thrombocytin in gel-filtration columns.</description><subject>Animals</subject><subject>Cattle</subject><subject>Crotalid Venoms - isolation &amp; purification</subject><subject>Crotalid Venoms - pharmacology</subject><subject>Endopeptidases - isolation &amp; purification</subject><subject>Endopeptidases - pharmacology</subject><subject>Factor V - metabolism</subject><subject>Factor Va</subject><subject>Humans</subject><subject>Peptide Hydrolases - isolation &amp; purification</subject><subject>Peptide Hydrolases - pharmacology</subject><subject>Serine Endopeptidases</subject><subject>Snakes</subject><subject>Viper Venoms - isolation &amp; purification</subject><subject>Viper Venoms - pharmacology</subject><issn>0076-6879</issn><issn>1557-7988</issn><isbn>0121819809</isbn><isbn>9780121819804</isbn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMlOwzAQhi0WlVL6CJVyQnAIeEm8nBCq2KRKHApcELIcZwKGJIbYqcTbky5iLnP4P43--RCaEXxBMOGXS4wFT7kU6kySc4kxzVK1h8Ykz0UqlJT76BgTSiRREqsDNP7nj9A0hE88TC4EE2SERgJnjCg6RvNXSt-SZWu-IFlB65vku_MRTICQxA8TE2OjW5kISVF7X6bWm_e-NtH5NqmGzHfJywk6rEwdYLrbE_R8e_M0v08Xj3cP8-tFahnJYqpEwWSRA6bYlsIUHDLgeWWVYtVQE1PBKmGBgmU5VFBxYihIY7kCzjLD2QSdbu8OFX96CFE3Llioa9OC74MWTGVckDU424F90UCpvzvXmO5X774e8qttDkPblYNOB-ugtVC6DmzUpXeaYL3Wrjfa9VqjlkRvtGvF_gCXhXEZ</recordid><startdate>1981</startdate><enddate>1981</enddate><creator>Kisiel, Walter</creator><creator>Canfield, William M.</creator><general>Elsevier Science &amp; Technology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>1981</creationdate><title>[22] Snake venom proteases that activate blood-coagulation factor V</title><author>Kisiel, Walter ; Canfield, William M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c314t-97b38b5e020cd7ab6e4e65fc993f6870273f7ce2ec35efef61a2e8ac69e634a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Animals</topic><topic>Cattle</topic><topic>Crotalid Venoms - isolation &amp; purification</topic><topic>Crotalid Venoms - pharmacology</topic><topic>Endopeptidases - isolation &amp; purification</topic><topic>Endopeptidases - pharmacology</topic><topic>Factor V - metabolism</topic><topic>Factor Va</topic><topic>Humans</topic><topic>Peptide Hydrolases - isolation &amp; purification</topic><topic>Peptide Hydrolases - pharmacology</topic><topic>Serine Endopeptidases</topic><topic>Snakes</topic><topic>Viper Venoms - isolation &amp; purification</topic><topic>Viper Venoms - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kisiel, Walter</creatorcontrib><creatorcontrib>Canfield, William M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Methods in Enzymology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kisiel, Walter</au><au>Canfield, William M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>[22] Snake venom proteases that activate blood-coagulation factor V</atitle><jtitle>Methods in Enzymology</jtitle><addtitle>Methods Enzymol</addtitle><date>1981</date><risdate>1981</risdate><volume>80</volume><spage>275</spage><epage>285</epage><pages>275-285</pages><issn>0076-6879</issn><eissn>1557-7988</eissn><isbn>0121819809</isbn><isbn>9780121819804</isbn><abstract>This chapter presents the procedure for purification and assaying of Russell's viper venom (RVV). The procedures for the isolation of RVV-V and thrombocytin used in this laboratory are virtually identical and include an initial gel filtration of the crude venom followed by final purification of the enzyme by SPSephadex ion-exchange chromatography. Because both of these enzymes are highly cationic, plasticware is recommended in the collection and storage of these proteins. In the assay venom protease is incubated with factor V substrate for a defined period. Following the incubation period, factor V is assayed by its ability to correct the clotting time of human factor V-deficient plasma following addition of tissue factor and calcium ions. The clotting times in this assay are proportional to the concentration of factor Va present in the incubation mixture, which in turn is directly related to the concentration of the venom factor V activator. In the assay of RVV-V, barium sulfateadsorbed plasma is a satisfactory source of factor V. In the assay of thrombocytin, however, partially purified factor V is required in that B. atrox venom contains a thrombin-like protease (batroxabin) that coelutes with thrombocytin in gel-filtration columns.</abstract><cop>United States</cop><pub>Elsevier Science &amp; Technology</pub><pmid>7043192</pmid><doi>10.1016/S0076-6879(81)80024-9</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0076-6879
ispartof Methods in Enzymology, 1981, Vol.80, p.275-285
issn 0076-6879
1557-7988
language eng
recordid cdi_proquest_miscellaneous_73946716
source MEDLINE; Elsevier ScienceDirect Journals Complete; ScienceDirect eBooks
subjects Animals
Cattle
Crotalid Venoms - isolation & purification
Crotalid Venoms - pharmacology
Endopeptidases - isolation & purification
Endopeptidases - pharmacology
Factor V - metabolism
Factor Va
Humans
Peptide Hydrolases - isolation & purification
Peptide Hydrolases - pharmacology
Serine Endopeptidases
Snakes
Viper Venoms - isolation & purification
Viper Venoms - pharmacology
title [22] Snake venom proteases that activate blood-coagulation factor V
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A06%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%5B22%5D%20Snake%20venom%20proteases%20that%20activate%20blood-coagulation%20factor%20V&rft.jtitle=Methods%20in%20Enzymology&rft.au=Kisiel,%20Walter&rft.date=1981&rft.volume=80&rft.spage=275&rft.epage=285&rft.pages=275-285&rft.issn=0076-6879&rft.eissn=1557-7988&rft.isbn=0121819809&rft.isbn_list=9780121819804&rft_id=info:doi/10.1016/S0076-6879(81)80024-9&rft_dat=%3Cproquest_pubme%3E73946716%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73946716&rft_id=info:pmid/7043192&rft_els_id=S0076687981800249&rfr_iscdi=true